Myopathy Clinical Trial
— NOSEPPOfficial title:
Prospective Observational Study: Comparison of Neurological Outcome in Septic Surgical, Septic Non-surgical and Non-septic Patients on ICU
Verified date | April 2017 |
Source | University of Rostock |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Systemic inflammation and sepsis cause multi organ failure including severe neurologic
impairment in the course of disease. Neurologic failure typically presents as
critical-illness-polyneuropathy/-myopathy and septic encephalopathy during sepsis and is
associated with an increased mortality rate.
Clinical parameters to determine the neurologic entities during the course of sepsis are
heterogeneous. Further research for an association of clinical parameters and the patients'
outcome is needed.
The study aims toward differences in the clinical and neurological outcome of surgical and
non-surgical septic patients in comparison to non-septic patients on ICU. The aim of the
study is to identify clinical and diagnostic outcome predictors in septic patients.
Status | Completed |
Enrollment | 32 |
Est. completion date | March 2017 |
Est. primary completion date | March 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Fulfilling criteria for severe sepsis or septic shock Exclusion Criteria: - Diagnosis of cerebrovascular disease (pre-existing) - Advanced dementia - Diagnosis of pre-existing other neuromuscular disease - High-dose glucocorticosteroid therapy (> 300 mg Hydrocortisone/die) - Pre-existing renal replacement therapy - Coagulation disorder with bleeding - Frequent administration of neuromuscular blocking agents (> 3 times/week) |
Country | Name | City | State |
---|---|---|---|
Germany | Intensive Care Units PIT 1+2, University hospital Rostock | Rostock |
Lead Sponsor | Collaborator |
---|---|
University of Rostock |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Septic Encephalopathy | EEG, MRT, CSF (cerebrospinal fluid) | day 7 | |
Primary | Critical-Illness-Polyneuropathy and -myopathy | ENG | day 7 | |
Primary | Septic Encephalopathy (28) | Clinical observation. | day 28 | |
Primary | Critical-Illness-Polyneuropathy and -myopathy (28) | Clinical observation. | day 28 | |
Secondary | - 28-day survival (observation time 100 days) | Survival after 28 days. | day 28 | |
Secondary | - Time of respirator-therapy | In days cumulative. | 1 year | |
Secondary | - Dosage of vasopressors (cumulative) | In days cumulative. | observation time 100 days | |
Secondary | - 100 day survival | Survival after 100 days. | day 100 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06374719 -
WiTNNess - TNNT1 Myopathy Natural History Study
|
||
Not yet recruiting |
NCT03633565 -
Comparative Study of Strategies for Management of Duchenne Myopathy (DM)
|
Phase 4 | |
Enrolling by invitation |
NCT02235220 -
Reduction of Masticatory Muscle Activity by Restoring Canine Guidance
|
N/A | |
Terminated |
NCT00278564 -
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
|
Phase 1 | |
Completed |
NCT01642056 -
EPI-743 for Metabolism or Mitochondrial Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02011282 -
Electro-Neuro-Muscular Stimulation in ICU
|
N/A | |
Completed |
NCT01702987 -
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
|
N/A | |
Active, not recruiting |
NCT01225614 -
Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive
|
Phase 3 | |
Recruiting |
NCT03749538 -
Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
|
N/A | |
Recruiting |
NCT01022450 -
Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
|
N/A | |
Withdrawn |
NCT00990834 -
Muscle Characteristics Associated With Statin Therapy
|
N/A | |
Active, not recruiting |
NCT00937001 -
Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
|
N/A | |
Recruiting |
NCT01353430 -
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
|
||
Completed |
NCT03751644 -
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
|
N/A | |
Completed |
NCT02765828 -
Identification of Tongue Involvement in Late-Onset Pompe Disease
|
||
Recruiting |
NCT05599568 -
Repeated Bout Effect i Neuromuscular Diseases
|
N/A | |
Withdrawn |
NCT02124070 -
Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis
|
Phase 1/Phase 2 | |
Completed |
NCT02706314 -
Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks.
|
||
Recruiting |
NCT03042286 -
SAPhIRE Statin Adverse Drug Reaction
|
||
Not yet recruiting |
NCT04941079 -
Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients :a Prospective Observational Study
|